Quantum Biopharma filed an innovation passport application in the U.K. to expedite the development and review of MS therapy ...

Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

Columnist Desiree Lama explores how living with MS led her to confront the comparison trap, ultimately finding strength in ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...

Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...

Talking to children about a parent’s multiple sclerosis diagnosis can help ease fears and keep your kids feeling connected.

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

A new low-cost generic form of Tecfidera is available in the U.S. for people with relapsing forms of MS for a fraction of the ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...